Yüklüyor......
Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism
Current strategies for the treatment of hereditary angioedema (HAE) include targeted inhibition or antagonism of the contact system, which is dysregulated in HAE patients by a C1 esterase inhibitor deficiency. Ecallantide, a plasma kallikrein inhibitor, and icatibant, a selective bradykinin-2 recept...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
World Allergy Organization
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3666151/ https://ncbi.nlm.nih.gov/pubmed/23282868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/1939-4551-3-S3-S34 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|